FDA DEVICE FACTS
Actinia® hip stems
Implantcast GmbH
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Actinia® hip stems are intende d to be use d in total hip arthroplasty for the following indications:
• Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;
• Rheumatoid arthritis;
• Treatment of non -union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable b y other techniques; and
• Revision of previously failed total hip arthroplasty. The Actinia® hip stems cementless are intended for uncemented, press-fit fixation. The Actinia® hip stems are intended to be used in partial (hemi) hip arthroplasty in conjunc tion with the ic -Bipolar Head System for the following indications:
• Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
• Rheumatoid arthritis
• Correction of functional deformity
• Treatment of non -union, femoral neck fr acture and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。